Affinity Oxygenator

Affinity™ Oxygenator

A proprietary oxygenator with heparin-coated Trillium™ biopassive surface for use during cardiopulmonary bypass procedures.
References in periodicals archive ?
Sales of the company's Affinity oxygenator line grew 32 percent in the quarter and sales of custom tubing packs were up 99 percent from the fourth quarter of 1995.
and common equivalent shares outstanding 7,968 7,972 7,767 7,307 Sales by Product Line 1996 1995 % 1996 1995 % Change Change Affinity Oxygenator Line $6,969 $5,281 32% $25,488 18,329 39% Signature Custom Tubing Packs 2,142 1,079 99% 7,402 3,459 114% Silicone Membrane Oxygenators 1,455 1,803 (19%) 7,517 7,793 (4%) Myotherm Cardioplegia Systems 1,082 961 13% 3,994 3,759 6%
Third quarter sales of the company's Affinity oxygenator line increased 38 percent and sales of custom tubing packs increased 105 percent from the third quarter of 1995.
Sales of our Affinity oxygenator line also continued to grow, while sales of our older silicone membrane technology declined as expected.
Our Affinity oxygenator continues to increase its market penetration, which helped increase revenue for the quarter to more than $10.
Most of the sales increase stemmed from strong sales of our Affinity oxygenator," said Anthony Badolato, chief executive officer.
Anthony Badolato, president and chief executive officer, said sales of the company's Affinity oxygenator line continued to grow rapidly, up 120 percent over the third quarter of last year to $4.
Our Affinity oxygenator line and custom tubing packs both continued to show strong sales growth over last year, while sales of our older oxygenator line continued to decline as expected," said Anthony Badolato, president and chief executive officer.
With the Affinity oxygenator as the centerpiece, the entire line has been designed to offer superior performance capabilities.
Most of the sales increase came from our new Affinity oxygenator, which we began to introduce to the domestic market during the quarter.
European sales of our new Affinity oxygenator came in on target for the year, and we also recorded good sales gains for the new Myotherm cardioplegia unit.
Food and Drug Administration to begin domestic marketing of its new Affinity oxygenator, the company announced today.